Is IEMG a Good ETF in 2026? Emerging Markets IMI for EU
IEMG ETF review 2026: iShares Core MSCI Emerging Markets IMI (US-listed) vs UCITS EIMI, VFEM. PRIIPs/W-8BEN limits, tax DE/FR/IT/ES/PL, broker access.
14 min czytaniaIs IEMG a Good ETF in 2026? iShares Core MSCI Emerging Markets IMI Deep Dive
TL;DR — Is IEMG a good ETF in 2026?
IEMG is one of the largest and cheapest emerging-market equity ETFs in the world — but it is US-listed and not directly purchasable by most EU retail investors due to PRIIPs disclosure rules. For EU investors, the practical answer is to use the UCITS equivalents EIMI (iShares Core MSCI EM IMI UCITS) or VFEM (Vanguard FTSE Emerging Markets UCITS), which give comparable exposure with EU-compliant documentation.
The native IEMG (US-listed, ISIN US46434G1031) is a good choice if:
- You're an EU citizen with US tax residency or a professional-classified account at IBKR/Saxo allowing US ETF access.
- You want the absolute cheapest EM IMI exposure (TER 0.09%, far below UCITS).
- You can accept US-domicile estate tax exposure above the US$60,000 threshold for non-residents.
- You can file US W-8BEN forms and reclaim foreign tax credits in your home country.
For the typical EU retail investor on Trade Republic, DEGIRO, Bossa or mBank, EIMI is the correct ticker to buy — IEMG won't appear in the order book because PRIIPs requires a KID/KIID that US-domiciled funds don't produce.
What is IEMG?
IEMG is the US-listed iShares Core MSCI Emerging Markets IMI ETF, issued by BlackRock Fund Advisors.
Fund facts:
| Attribute | Value (US IEMG) |
|---|---|
| ISIN | US46434G1031 |
| Issuer | iShares (BlackRock Fund Advisors) |
| Index tracked | MSCI Emerging Markets Investable Market Index (large + mid + small cap) |
| Holdings count | ~2,800 stocks |
| AUM | ~USD 85 billion (early 2026) |
| TER (Expense ratio) | 0.09% per year |
| Domicile | United States |
| Distribution policy | Distributing — quarterly |
| Replication method | Physical, optimised sampling |
| Inception date | October 2012 |
| Trading currency | USD (NYSE Arca) |
The MSCI EM IMI covers approximately 99% of the free float-adjusted EM equity universe across 24 countries, including China (~28%), India (~20%), Taiwan (~18%), South Korea (~12%), Brazil (~5%), Saudi Arabia, Mexico, South Africa and others. The "IMI" qualifier means it includes small caps, giving slightly broader exposure than the standard MSCI EM (large + mid only).
Why most EU investors cannot buy IEMG directly
Since the EU PRIIPs Regulation (effective 2018), any packaged retail investment product sold to EU retail investors must have a Key Information Document (KID) in the buyer's language. US-domiciled ETFs do not produce KIDs, so EU brokers block them for retail orders. Even if your broker shows the ticker, the buy button will be disabled unless you're classified as a professional client or based in a jurisdiction outside the PRIIPs regime.
The practical workaround for nearly all EU retail investors is to use the UCITS equivalents.
UCITS equivalents available to EU investors
| Ticker | Fund | TER | Holdings | Index family |
|---|---|---|---|---|
| EIMI | iShares Core MSCI EM IMI UCITS ACC | 0.18% | ~3,000 | MSCI EM IMI |
| VFEM | Vanguard FTSE Emerging Markets UCITS DIST | 0.22% | ~1,900 | FTSE EM |
| EMIM | iShares MSCI EM IMI UCITS ACC (alt ticker) | 0.18% | ~3,000 | Same as EIMI |
| HMEM | HSBC MSCI Emerging Markets UCITS ACC | 0.15% | ~1,400 | MSCI EM standard (no small caps) |
EIMI (ISIN IE00BKM4GZ66) is the direct UCITS equivalent of IEMG — same index family (MSCI EM IMI), same issuer (iShares), Irish-domiciled, accumulating. The TER is 0.18% (vs 0.09% for native IEMG), a 9 basis point premium that buys you EU-compliant documentation and access.
VFEM (ISIN IE00B3VVMM84) tracks the FTSE EM index, which includes South Korea (MSCI does not) and excludes a few other markets. The methodological differences result in roughly 1-2 percentage points of tracking divergence over time.
5-year performance (UCITS proxy via EIMI)
Since most readers will hold the UCITS equivalent, the relevant historical data through early 2026:
| Metric | 5-year value (EIMI) |
|---|---|
| Annualised total return (EUR) | ~+3.5% |
| Cumulative return (EUR) | ~+19% |
| Max drawdown (2022) | ~-22% |
| Sharpe ratio | ~0.20 |
| Tracking error vs MSCI EM IMI | ~0.30% |
Emerging-market returns have lagged developed markets for most of the 2014-2025 cycle, driven by Chinese underperformance, USD strength, and EM corporate earnings disappointments. Many investors consider EM a long-cycle valuation bet — the price/earnings discount vs DM is wide by historical standards, but mean reversion is uncertain.
Total cost of ownership
For a EUR 1,000 monthly DCA investor using EIMI (the practical EU vehicle):
| Cost component | Annual EUR (on EUR 12,000 contributed) |
|---|---|
| TER 0.18% (EIMI) | ~EUR 22 (on portfolio, growing) |
| Bid-ask spread on Xetra (~0.10%) | ~EUR 12 |
| FX margin (EUR account, EUR trade) | EUR 0 |
| Broker commission (TR/Scalable savings plan) | EUR 0 |
| Broker commission (Polish IKE via Bossa) | ~EUR 12-24 per year |
For comparison, if an EU professional client could access native IEMG: TER 0.09% saves ~EUR 11 per year on a EUR 12,000 portfolio, but adds USD conversion cost, US W-8BEN paperwork, and US estate-tax risk above US$60,000.
Tax treatment per EU country
For the practical UCITS vehicle (EIMI/VFEM), historical data shows the following typical framework:
- Germany: Equity ETF → 30% Teilfreistellung. 25% Abgeltungssteuer + Soli on remaining 70%.
- France: Not PEA-eligible (Irish-domiciled, non-EU equity). In CTO: flat 30% PFU.
- Italy: 26% capital gains tax on disposal; accumulating EIMI defers to sale.
- Spain: 19-28% progressive CGT on disposal.
- Netherlands: Box 3 wealth tax on portfolio value year-end.
- Poland: 19% Belka on disposal, PIT-38. Inside IKE/IKZE, gains exempt subject to retirement-age rules.
For native US IEMG (if accessible): the US 15% withholding on dividends (subject to W-8BEN treaty rates) reduces yield. Critically, US-domiciled holdings above US$60,000 are subject to US estate tax for non-US persons — a meaningful risk that does not apply to Irish-domiciled UCITS funds.
Alternatives comparison
| Ticker | Fund | TER | EU-buyable? | Notes |
|---|---|---|---|---|
| IEMG | iShares Core MSCI EM IMI (US-listed) | 0.09% | No (PRIIPs) | Cheapest, but blocked for EU retail |
| EIMI | iShares Core MSCI EM IMI UCITS ACC | 0.18% | Yes | Direct UCITS equivalent of IEMG |
| EMIM | iShares MSCI EM IMI UCITS ACC | 0.18% | Yes | Same fund as EIMI, alt ticker |
| VFEM | Vanguard FTSE EM UCITS DIST | 0.22% | Yes | FTSE family, includes South Korea differently |
| HMEM | HSBC MSCI EM UCITS ACC | 0.15% | Yes | Cheapest UCITS, no small caps |
| FEMU | Fidelity MSCI EM UCITS ACC | 0.20% | Yes | Newer, smaller AUM |
IEMG vs EIMI: same exposure, same issuer, same index. EIMI's 9 bp TER premium is the price of EU compliance.
EIMI vs VFEM: different index methodologies. EIMI tracks MSCI EM IMI (small-caps included). VFEM tracks FTSE EM (different country list — historically included South Korea, while MSCI classified Korea as DM). The choice between the two is more about index philosophy than cost.
When IEMG (UCITS variant) is the best choice
- You want broad EM exposure including small caps. EIMI/IEMG IMI captures small caps that the standard MSCI EM (HMEM) excludes.
- You're a professional-classified EU investor with US ETF access. Native IEMG saves you 9 basis points per year, materially over decades.
- You're building a globally diversified portfolio with EUNL/IWDA as your DM core. EIMI (the EU-accessible variant) is the obvious EM complement.
- You want iShares brand and BlackRock scale. EIMI is one of the largest UCITS EM ETFs available.
When IEMG is NOT the best choice
- You're an EU retail investor. Native IEMG is blocked. Use EIMI instead.
- You prefer FTSE methodology over MSCI. VFEM is the natural alternative.
- You want a single-fund global solution. VWCE includes EM (~10%) in one ticker — no need for a separate EM sleeve.
- You want to avoid China exposure. EIMI/IEMG is ~28% China. Funds like FLXG or specific ex-China EM ETFs serve that need.
Broker availability
Native IEMG: Only accessible via Interactive Brokers / Saxo / DriveWealth with professional classification, or through US-resident accounts. Most EU retail brokers (Trade Republic, Scalable, DEGIRO, Bossa, mBank) block US ETFs for retail per PRIIPs.
EIMI (the practical EU vehicle):
- Trade Republic — savings plan from EUR 1.
- Scalable Capital — savings plan, PRIME+ free trades.
- Trading 212 — commission-free, fractional shares supported.
- DEGIRO — included in Core Selection.
- Interactive Brokers — flat ~EUR 1.25 Xetra trade fee.
- Polish brokers (https://bossa.pl, https://www.mbank.pl) — available for IKE/IKZE.
How Freenance helps you track IEMG / EIMI
In Freenance, the EM sleeve typically sits next to your DM core (EUNL/IWDA) and your bond sleeve (AGGH). You can run a multi-ETF portfolio view, simulate rebalancing back to a target DM/EM/Bond split (e.g. 60/20/20), DCA into each independently, track dividend reinvestment for EIMI (accumulating) automatically, and use the Financial Freedom Runway to model how the blended portfolio funds your real monthly expenses.
FAQ
Can I buy IEMG as a retail investor in Germany / France / Italy / Poland? No. The PRIIPs Regulation blocks US-domiciled ETFs from EU retail buyers. Use EIMI instead.
Is EIMI better than VFEM? EIMI tracks MSCI EM IMI (small caps included, ~3,000 stocks, TER 0.18%). VFEM tracks FTSE EM (different country mix, ~1,900 stocks, TER 0.22%, distributing). EIMI is broader and accumulating; VFEM has a different country list and pays quarterly.
Is EIMI synthetic or physical? Physical, optimised sampling. With ~3,000 holdings and many illiquid EM names, full replication is impractical.
What is the dividend yield on EIMI / native IEMG? EIMI is accumulating — dividends are reinvested. The MSCI EM IMI gross yield in 2026 is approximately 2.5%, captured in NAV growth. Native US IEMG distributes ~2.4% net of US withholding, paid quarterly.
Can I hold EIMI in a French PEA? No. Not PEA-eligible. For PEA-wrapped EM exposure look at Amundi PEA EM synthetic variants.
Should I hold VWCE instead of EUNL + EIMI? VWCE = 1 fund, ~3,700 stocks, includes EM at index weight. EUNL + EIMI = 2 funds, manual rebalancing, but lets you over- or under-weight EM independently. Most investors pick VWCE for simplicity; some sophisticated investors prefer the EUNL + EIMI split for control.
Country and sector composition deep dive
The MSCI Emerging Markets IMI is concentrated in a small number of large EM markets. Historical data through early 2026 shows the following approximate composition:
| Country | Weight in MSCI EM IMI |
|---|---|
| China | ~28% |
| India | ~20% |
| Taiwan | ~18% |
| South Korea | ~12% |
| Brazil | ~5% |
| Saudi Arabia | ~4% |
| South Africa | ~3% |
| Mexico | ~2% |
| Indonesia | ~2% |
| Thailand | ~2% |
| Other EM | ~4% |
By GICS sector: Information Technology ~22% (driven by Taiwan Semiconductor and Korean tech), Financials ~22%, Consumer Discretionary ~13%, Communication Services ~9%, Industrials ~7%, Materials ~7%, Energy ~5%, Consumer Staples ~5%, Health Care ~4%, Utilities ~3%, Real Estate ~3%.
The China exposure is the single most controversial factor in EM ETFs. Investors who want EM growth without single-country political risk often use "EM ex-China" alternatives or split allocations between EIMI/IEMG (with China) and a separate India or Vietnam tilt. Many investors consider the China weight a fair reflection of EM's actual investable opportunity set, while others view it as concentrated geopolitical exposure that doesn't belong in their core.
DCA example: 10-year accumulation scenario via EIMI
Consider a EUR 500/month DCA into EIMI (the EU-accessible IEMG equivalent) over 10 years (EUR 60,000 contributed). Using an approximate ~6% total return assumption for EM (lower than DM long-term expectation):
| Year | Contributed | Estimated portfolio value | Cumulative TER paid |
|---|---|---|---|
| 1 | EUR 6,000 | ~EUR 6,180 | ~EUR 10 |
| 3 | EUR 18,000 | ~EUR 19,300 | ~EUR 65 |
| 5 | EUR 30,000 | ~EUR 34,500 | ~EUR 200 |
| 10 | EUR 60,000 | ~EUR 80,200 | ~EUR 820 |
EM forward returns are highly uncertain. Many investors hold EIMI as a long-horizon valuation bet — EM P/E and P/B ratios have been at meaningful discounts to DM for over a decade, with the implied premium for the eventual mean reversion.
Common mistakes IEMG / EIMI investors make
- Trying to buy native IEMG from an EU retail account. It will be blocked or rejected. Use EIMI.
- Buying both EIMI and EMIM. They are the same fund under different exchange tickers. You are duplicating, not diversifying.
- Holding VWCE plus EIMI in a 50/50 split. VWCE already includes ~10% EM. Adding 50% EIMI gives roughly ~55% EM in total — a massive overweight that may not match your actual conviction.
- Selling during 2022-2023 China sell-offs. EM bottomed in late 2022; selling at the bottom locked in losses for many investors.
- Confusing FTSE EM (VFEM) with MSCI EM IMI (EIMI/IEMG). FTSE has historically classified countries differently — checking the index methodology matters before claiming "exposure to country X."
How EIMI fits in a multi-asset portfolio
Many investors consider the DM + EM split a core portfolio decision rather than an afterthought. Sample portfolio constructions:
- Market-weight global: 88% EUNL + 12% EIMI + AGGH defensive sleeve. Replicates approximately what VWCE does in two funds, with the freedom to over- or under-weight EM independently.
- EM-tilted growth: 70% EUNL + 25% EIMI + 5% cash. Higher EM exposure than market weight; suitable for investors with strong long-horizon EM conviction.
- Three-pillar: 50% EUNL + 25% EIMI + 25% AGGH. Equal-weighted core, EM tilt, defensive bonds.
- VWCE + EIMI tilt: 80% VWCE + 20% EIMI. Already includes EM via VWCE; the satellite doubles the EM weight to ~28% total.
The choice between holding VWCE alone vs splitting into EUNL + EIMI is primarily a question of operational control. VWCE is one decision per month; EUNL + EIMI is two decisions plus periodic rebalancing. The cost difference is marginal (~1-3 basis points in blended TER). For most investors, simplicity wins.
Sources
- iShares (BlackRock Fund Advisors and BlackRock Asset Management Ireland) fund factsheets and KIDs
- MSCI Inc. — MSCI Emerging Markets IMI methodology
- FTSE Russell — FTSE Emerging Markets methodology
- ESMA — PRIIPs Regulation Q&A
- Xetra and NYSE Arca segment statistics
Informational content, not investment advice. Past performance does not guarantee future results. Tax treatment depends on individual circumstances and may change. Always verify current data with the issuer and a qualified tax advisor in your country of residence.
Want full control over your finances?
Try Freenance for free